Aetna Inc. (NYSE:AET) has earned a consensus rating of “Buy” from the twenty-four research firms that are presently covering the company, MarketBeat.com reports. Seven equities research analysts have rated the stock with a hold recommendation and seventeen have issued a buy recommendation on the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $160.54.

A number of equities analysts recently commented on AET shares. Citigroup Inc. started coverage on Aetna in a report on Wednesday, June 28th. They issued a “buy” rating and a $180.00 price objective on the stock. Barclays PLC restated an “overweight” rating and issued a $162.00 price objective on shares of Aetna in a report on Monday, May 15th. Credit Suisse Group restated a “buy” rating and issued a $155.00 price objective on shares of Aetna in a report on Wednesday, May 17th. BidaskClub downgraded Aetna from a “strong-buy” rating to a “buy” rating in a report on Wednesday, July 19th. Finally, Royal Bank Of Canada increased their price objective on Aetna from $147.00 to $162.00 and gave the stock an “outperform” rating in a report on Friday, June 9th.

ILLEGAL ACTIVITY WARNING: “Aetna Inc. (AET) Given Average Rating of “Buy” by Analysts” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright laws. The original version of this story can be read at https://www.thecerbatgem.com/2017/09/13/aetna-inc-aet-given-average-rating-of-buy-by-analysts.html.

Several institutional investors have recently made changes to their positions in the company. BlackRock Inc. grew its stake in shares of Aetna by 3,374.9% in the first quarter. BlackRock Inc. now owns 30,712,219 shares of the company’s stock worth $3,917,344,000 after acquiring an additional 29,828,390 shares during the last quarter. Vanguard Group Inc. grew its stake in shares of Aetna by 3.8% in the first quarter. Vanguard Group Inc. now owns 23,117,526 shares of the company’s stock worth $2,948,640,000 after acquiring an additional 838,578 shares during the last quarter. Capital World Investors grew its stake in shares of Aetna by 8.9% in the second quarter. Capital World Investors now owns 20,769,004 shares of the company’s stock worth $3,153,358,000 after acquiring an additional 1,688,767 shares during the last quarter. FMR LLC grew its stake in shares of Aetna by 73.8% in the second quarter. FMR LLC now owns 13,736,800 shares of the company’s stock worth $2,085,659,000 after acquiring an additional 5,833,567 shares during the last quarter. Finally, Bank of New York Mellon Corp grew its stake in shares of Aetna by 3.9% in the first quarter. Bank of New York Mellon Corp now owns 4,378,982 shares of the company’s stock worth $558,540,000 after acquiring an additional 165,278 shares during the last quarter. Institutional investors and hedge funds own 89.58% of the company’s stock.

Aetna (NYSE:AET) traded down 0.23% during midday trading on Tuesday, reaching $162.83. 2,148,245 shares of the company’s stock traded hands. The stock has a market capitalization of $54.08 billion, a price-to-earnings ratio of 36.14 and a beta of 0.53. Aetna has a 52 week low of $104.59 and a 52 week high of $164.52. The company’s 50-day moving average price is $156.47 and its 200 day moving average price is $144.33.

Aetna (NYSE:AET) last released its quarterly earnings data on Thursday, August 3rd. The company reported $3.42 EPS for the quarter, topping analysts’ consensus estimates of $2.34 by $1.08. Aetna had a return on equity of 20.52% and a net margin of 2.52%. The firm had revenue of $15.52 billion for the quarter, compared to the consensus estimate of $15.34 billion. During the same quarter in the prior year, the company posted $2.21 earnings per share. The firm’s revenue was down 2.7% on a year-over-year basis. On average, equities research analysts expect that Aetna will post $9.54 earnings per share for the current year.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Analyst Recommendations for Aetna (NYSE:AET)

Receive News & Stock Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related stocks with our FREE daily email newsletter.